Company Overview
- Headquarters
- 131 Oyster Point Blvd, South San Francisco CA
- Website
- vergegenomics.com
- Employees
- 64
- Founded in
- 2015
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Verge Genomics
Verge Genomics is a biotechnology startup based in South San Francisco, California. Currently employing 64 people, the company has generated $50 million in revenue. Verge Genomics develops next-generation biopharmaceutical treatments for neurodegenerative diseases, utilizing systems biology to expedite the drug development process. Their platform integrates patient genomes, gene expression data, and epigenomics to pinpoint new therapeutic gene targets, predict effective medications, and categorize patient groups for improved clinical outcomes. Verge Genomics differentiates itself through its innovative approach, which aims to identify drugs that significantly enhance patient outcomes while reducing the overall cost of pharmaceutical development. To learn more about Verge Genomics, visit their website at vergegenomics.com.
Company Leadership
Verge Genomics Industry Tags
Verge Genomics Tech Stack
Companies Similar to Verge Genomics
Analyze industry trends and opportunities by examining competitors and companies comparable to Verge Genomics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |